Premium
Clinical implications of high‐sensitivity cardiac troponins
Author(s) -
Holzmann M. J.
Publication year - 2018
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.12779
Subject(s) - medicine , myocardial infarction , chest pain , troponin , cardiology , emergency department , myocardial infarction diagnosis , population , disease , troponin t , intensive care medicine , environmental health , psychiatry
Abstract Cardiac troponin assays have become more sensitive over the years leading to the clinical introduction of high‐sensitivity cardiac troponin assays in 2010. Their use has revolutionized the assessment of patients with chest pain in the emergency department by allowing earlier rule‐in and rule‐out of myocardial infarction leading to shorter stays in the emergency department and reduced admissions for chest pain. The incidence of myocardial infarction has increased slightly, and patients with myocardial infarction diagnosed with high‐sensitivity cardiac troponins have been found to have a reduced risk of reinfarction, though without an impact on survival. High‐sensitivity cardiac troponins are powerful predictors of long‐term mortality and cardiovascular disease in the general population as well as in patients with chest pain with or without cardiovascular disease. The increase in risk for death and cardiovascular disease associated with high‐sensitivity cardiac troponins is graded and starts already at detectable levels, well below the upper normal level. The aim of this review was to describe the clinical use and consequences of the introduction of high‐sensitivity cardiac troponins. In addition, the importance of persistently elevated troponin levels for prognosis and what investigations may be appropriate to perform in patients with stable troponin elevations are discussed.